No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial
Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial
Avecho to Push Forward With Phase III Trial of Anti-Insomnia Drug
Avecho Biotechnology Secures Ethics Clearance for Phase Three Insomnia Trial
Stocks of the Hour: Dotz Nano, Immuron, Avecho Biotechnology
Avecho Biotechnology (ASX:AVE) Passes "Crucial" Two-year Stability Milestone for CBD Capsule
No Data